A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8684459.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The adenoviral oncoprotein E1A induces progression through the cell cycle by binding to the products of the p300/CBP and retinoblastoma gene families. A new cellular p300/CBP-associated factor (P/CAF) having intrinsic histone acetylase activity has been identified that competes with E1A. Exogenous expression of P/CAF in HeLa cells inhibits cell-cycle progression and counteracts the mitogenic activity of E1A. E1A disturbs the normal cellular interaction between p300/CBP and its associated histone acetylase.
Medical subject headings
- Adenovirus E1A Proteins
- Cell Cycle Proteins
- Nuclear Proteins
- Saccharomyces cerevisiae Proteins
- Trans-Activators
- Transcription Factors